Skip to content

Photobiomodulation for women with endometriosis

Photobiomodulation in women with endometriosis and pelvic floor myofascial pain: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-42cms7j
Enrollment
177
Registered
2026-01-20
Start date
2025-09-02
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic floor Endometriosis

Interventions

This is a randomized, evaluator-blinded, concealed-allocation clinical trial. This clinical trial will be conducted in accordance with the Consolidated Standards of Reporting Trials. Regarding sample
Group 2 (G2): continuous mode, energy of 4J, at 142.8J/cm2 per point, total energy of 24J and irradiation time of 40 seconds per point
Group 3 (G3): Sham group - will be performed with the device switched off.

Sponsors

Maternidade Escola Assis Chateaubriand
Lead Sponsor
Maternidade Escola Assis Chateaubriand
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women receiving care at the Pelvic Physiotherapy outpatient clinic of Assis Chateaubriand Maternity School; over 18 years of age; diagnosed with deep endometriosis by ultrasound with mapping; who have not undergone previous endometriosis surgery; women who, during the physical examination (one-finger palpation of the pelvic floor muscles), present any level of pain during the increase in digital pressure performed by intravaginal manual examination towards the muscle tissue, which will be performed by a single evaluator; women who do not have cognitive dysfunctions that affect the understanding of the proposed activities and application of the questionnaires, obtaining a cutoff point of 20 on the Mini-Mental State Examination

Exclusion criteria

Exclusion criteria: Women reporting signs and symptoms of urinary tract infection; history of cancer, pelvic radiotherapy, or brachytherapy; pregnant women or women trying to conceive; continuous use of analgesic, narcotic, and muscle relaxant medications; genital prolapse grade III and IV (according to the Pelvic Organ Prolapse Quantification System); patients using photosensitive medicationsons

Design outcomes

Primary

MeasureTime frame
Pain intensity is expected to be assessed using the Visual Analogue Scale (VAS) – during the anamnesis (characteristics of the pain) and physical examination, evaluating the pelvic floor muscles through palpation of standardized points

Secondary

MeasureTime frame
The impact of symptoms on the pelvic floor is expected to be assessed using the Pelvic Floor Impact Questionnaire (PFIQ-7);It is expected that a poorer quality of life will be found using the Endometriosis Health Profile Questionnaire - EPH-30.

Countries

BR

Contacts

Public ContactIsabella Frota

Maternidade Escola Assis Chateaubriand

isabella.frota@ebserh.gov.br+55-85-991776588

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: May 1, 2026